The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin (Q28474925)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

Vanessa Almendro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Susana García-Recio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ignasi Casas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Josep M Augé

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Joan Maurel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Pedro Gascón

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

English

0 references

publication date

6 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

e4728

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

22 January 2020

start time

6 March 2009

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

The role of receptor internalization in CD95 signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

New functions for the matrix metalloproteinases in cancer progression

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Paraffin-embedded cell line microarray (PECLIMA): development and validation of a high-throughput method for antigen profiling of cell lines

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Tumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Does CD95 have tumor promoting activities?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Exposure of Human Primary Colon Carcinoma Cells to Anti-Fas Interactions Influences the Emergence of Pre-existing Fas-Resistant Metastatic Subpopulations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Particular aspects of platinum compounds used at present in cancer treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Induction of apoptosis by cancer chemotherapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Overview of matrix metalloproteinase expression in cultured human cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Changing views of the role of matrix metalloproteinases in metastasis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity

2 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0004728

Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0004728

Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0004728

Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0004728

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0004728

Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648894

Soluble Fas in serum from patients with renal cell carcinoma

27 November 2018

1 reference

12 December 2020

p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines

1 reference

12 December 2020

Increased serum levels of soluble Fas in progressive B-CLL

1 reference

12 December 2020

Significance of serum soluble Fas ligand in patients with bladder carcinoma

1 reference

12 December 2020

Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo

1 reference

12 December 2020

The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis

1 reference

12 December 2020

Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma

1 reference

12 December 2020

Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0004728

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

19266094

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19266094%20AND%20SRC:MED&resulttype=core&format=json